Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Boehringer Ingelheim
Moodys
Colorcon
Dow

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: LANREOTIDE ACETATE

See Plans and Pricing

« Back to Dashboard

LANREOTIDE ACETATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Ipsen Pharma SOMATULINE DEPOT lanreotide acetate SOLUTION;SUBCUTANEOUS 022074 NDA Ipsen Biopharmaceuticals, Inc. 15054-1060-3 1 POUCH in 1 CARTON (15054-1060-3) > 1 SYRINGE in 1 POUCH > .2 mL in 1 SYRINGE
Ipsen Pharma SOMATULINE DEPOT lanreotide acetate SOLUTION;SUBCUTANEOUS 022074 NDA Ipsen Biopharmaceuticals, Inc. 15054-1060-4 1 POUCH in 1 CARTON (15054-1060-4) > 1 SYRINGE in 1 POUCH > .2 mL in 1 SYRINGE
Ipsen Pharma SOMATULINE DEPOT lanreotide acetate SOLUTION;SUBCUTANEOUS 022074 NDA Ipsen Biopharmaceuticals, Inc. 15054-1090-3 1 POUCH in 1 CARTON (15054-1090-3) > 1 SYRINGE in 1 POUCH > .3 mL in 1 SYRINGE
Ipsen Pharma SOMATULINE DEPOT lanreotide acetate SOLUTION;SUBCUTANEOUS 022074 NDA Ipsen Biopharmaceuticals, Inc. 15054-1090-4 1 POUCH in 1 CARTON (15054-1090-4) > 1 SYRINGE in 1 POUCH > .3 mL in 1 SYRINGE
Ipsen Pharma SOMATULINE DEPOT lanreotide acetate SOLUTION;SUBCUTANEOUS 022074 NDA Ipsen Biopharmaceuticals, Inc. 15054-1120-3 1 POUCH in 1 CARTON (15054-1120-3) > 1 SYRINGE in 1 POUCH > .5 mL in 1 SYRINGE
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
McKesson
Mallinckrodt
McKinsey
Baxter